Critical Reviews in Oncology / Hematology
Volume 77, Issue 2 , Pages 142-147, February 2011

Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question

  • Catherine Terret

      Affiliations

    • Centre Léon Bérard, Lyon, France
    • PROLOG (Lyon Oncogeriatric Program, French National Cancer Institute-INCa), France
    • Claude-Bernard-Lyon-1 University, Lyon, France
    • Corresponding Author InformationCorresponding author at: Medical Oncology Department, Centre Léon Bérard, 28, rue Laennec, 69373 Lyon Cedex 08, France. Tel.: +33 04 78 78 27 57; fax: +33 04 78 78 27 16.
  • ,
  • Gilles Albrand

      Affiliations

    • PROLOG (Lyon Oncogeriatric Program, French National Cancer Institute-INCa), France
    • Claude-Bernard-Lyon-1 University, Lyon, France
    • Comprehensive Geriatric Assessment Unit, Hôpital Gériatrique Antoine Charial, Francheville, France
  • ,
  • Géraldine Moncenix

      Affiliations

    • Centre Léon Bérard, Lyon, France
    • PROLOG (Lyon Oncogeriatric Program, French National Cancer Institute-INCa), France
  • ,
  • Jean Pierre Droz

      Affiliations

    • Centre Léon Bérard, Lyon, France
    • PROLOG (Lyon Oncogeriatric Program, French National Cancer Institute-INCa), France
    • Claude-Bernard-Lyon-1 University, Lyon, France

Accepted 27 January 2010. published online 25 February 2010.

Abstract 

Oncologists usually base treatment decision on the assessment of patients’ performance status (PS). This study was undertaken to explore the ability of KPS to correctly assess the PS of elderly cancer patients, comparing it to a validated geriatric tool named Physical Performance Test (PPT).

One single examiner assessed elderly cancer patients’ PS at registration in our institution and performed the PPT on patients with KPS ≥60. A sample of 152 patients actually underwent PPT. A low refusal rate was observed (<5%). Most patients (82%) had a high PS (KPS ≥80), whereas only 20% had no health impairment according to PPT scores. Patients’ gender and disease stage did not correlate with PPT scores.

The KPS seems to be a less accurate tool than the PPT to assess functional status of elderly cancer patients. Then PPT could be used as an inclusion criterion instead of KPS before cancer treatment decision.

Keywords: Cancer in the elderly, Geriatric oncology, Performance status, Screening tool, Geriatric assessment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1040-8428(10)00030-2

doi:10.1016/j.critrevonc.2010.01.015

Critical Reviews in Oncology / Hematology
Volume 77, Issue 2 , Pages 142-147, February 2011